down arrow

Aurobindo Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE406A01037
  • NSEID: AUROPHARMA
  • BSEID: 524804
INR
1,221.25
-2.4 (-0.2%)
BSENSE

Dec 05

BSE+NSE Vol: 1.91 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
8,285.70
7,868.14
8,382.12
7,978.52
7,796.07
7,567.02
7,580.15
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
8,285.70
7,868.14
8,382.12
7,978.52
7,796.07
7,567.02
7,580.15
Raw Material Cost
2,509.80
2,535.16
2,799.51
2,728.74
2,741.85
2,466.66
2,634.88
Purchase of Finished goods
846.05
807.80
636.18
823.89
747.03
680.01
785.95
(Increase) / Decrease In Stocks
-16.99
-103.74
-7.81
-237.22
-278.61
-73.99
-359.95
Employee Cost
1,277.33
1,228.80
1,162.64
1,131.55
1,109.48
1,071.95
1,026.32
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
1,991.41
1,797.09
1,999.68
1,953.58
1,910.18
1,802.82
1,820.14
Total Expenditure (Excl Depreciation)
6,607.60
6,265.11
6,590.20
6,400.54
6,229.93
5,947.45
5,907.34
Operating Profit (PBDIT) excl Other Income
1,678.10
1,603.03
1,791.92
1,577.98
1,566.14
1,619.57
1,672.81
Other Income
120.59
105.30
134.81
157.29
136.00
220.93
135.62
Operating Profit (PBDIT)
1,798.69
1,708.33
1,926.73
1,735.27
1,702.14
1,840.50
1,808.43
Interest
95.24
97.75
115.02
118.48
112.70
111.04
89.43
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
-122.11
Gross Profit (PBDT)
1,703.45
1,610.58
1,811.71
1,616.79
1,589.44
1,729.46
1,596.89
Depreciation
429.19
405.70
444.43
418.53
382.28
404.18
354.33
Profit Before Tax
1,275.92
1,206.80
1,335.09
1,199.85
1,207.46
1,323.89
1,229.90
Tax
427.79
382.60
432.26
354.28
390.51
405.67
322.55
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
846.47
822.28
935.02
843.98
816.65
919.61
920.01
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
846.47
822.28
935.02
843.98
816.65
919.61
920.01
Share in Profit of Associates
1.66
1.92
-32.19
1.59
0.30
-1.39
-12.66
Minority Interest
-0.32
-0.55
-0.64
-0.24
-0.43
-1.00
-1.40
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
848.45
824.75
903.47
845.81
817.38
919.22
908.75
Equity Capital
58.08
58.08
58.08
58.08
58.08
58.59
58.59
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
30,820.31
0.00
0.00
Earnings per share (EPS)
14.61
14.2
15.56
14.56
14.07
15.69
15.51
Diluted Earnings per share
14.61
14.2
15.56
14.56
14.0
15.69
15.51
Operating Profit Margin (Excl OI)
20.37%
20.57%
21.38%
19.99%
20.48%
21.72%
22.33%
Gross Profit Margin
20.68%
20.67%
21.62%
20.48%
20.79%
23.19%
21.31%
PAT Margin
10.3%
10.58%
10.77%
10.71%
10.68%
12.31%
12.11%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is 5.31% vs -6.13% in Jun 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is 2.87% vs -8.71% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is 4.68% vs -10.54% in Jun 2025

stock-summary

Interest

QoQ Growth in quarter ended Sep 2025 is -2.57% vs -15.01% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

Compare Quarterly Results Of Aurobindo Pharma With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
8,285.70
3,697.16
4,588.54
124.11%
Other Operating Income
0.00
0.00
0.00
Total Operating income
8,285.70
3,697.16
4,588.54
124.11%
Raw Material Cost
2,509.80
594.36
1,915.44
322.27%
Purchase of Finished goods
846.05
412.97
433.08
104.87%
(Increase) / Decrease In Stocks
-16.99
54.84
-71.83
-130.98%
Employee Cost
1,277.33
825.18
452.15
54.79%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
1,991.41
888.48
1,102.93
124.14%
Total Expenditure (Excl Depreciation)
6,607.60
2,775.83
3,831.77
138.04%
Operating Profit (PBDIT) excl Other Income
1,678.10
921.33
756.77
82.14%
Other Income
120.59
91.87
28.72
31.26%
Operating Profit (PBDIT)
1,798.69
1,013.20
785.49
77.53%
Interest
95.24
169.68
-74.44
-43.87%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
1,703.45
843.52
859.93
101.95%
Depreciation
429.19
221.82
207.37
93.49%
Profit Before Tax
1,275.92
624.02
651.90
104.47%
Tax
427.79
103.84
323.95
311.97%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
846.47
517.86
328.61
63.46%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
846.47
517.86
328.61
63.46%
Share in Profit of Associates
1.66
2.32
-0.66
-28.45%
Minority Interest
-0.32
8.67
-8.99
-103.69%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
848.45
511.51
336.94
65.87%
Equity Capital
58.08
41.28
16.80
40.70%
Face Value
1.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
14.61
12.39
2.22
17.92%
Diluted Earnings per share
14.61
12.38
2.23
18.01%
Operating Profit Margin (Excl OI)
20.37%
24.92%
0.00
-4.55%
Gross Profit Margin
20.68%
22.82%
0.00
-2.14%
PAT Margin
10.30%
14.07%
0.00
-3.77%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 8,285.70 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 5.31% vs -6.13% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 6.28% vs 7.99% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 848.45 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 2.87% vs -8.71% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 3.80% vs 7.95% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,678.10 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 4.68% vs -10.54% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 7.15% vs 14.03% in Sep 2024

Quarterly - Interest
Interest 95.24 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is -2.57% vs -15.01% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -15.49% vs 65.30% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.37%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."